Nitric oxide involvement in additive antidepressant-like effect of agmatine and lithium in mice forced swim test
| Autor: | Vahid Nikoui, Samira Zolfaghari, Ahmad Reza Dehpour, Abouzar Moradi, Sattar Ostadhadi, Abbas Norouzi-Javidan |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
0301 basic medicine Indazoles Agmatine Arginine Lithium (medication) Central nervous system Pharmacology Nitric Oxide Guanidines Antidepressant like Nitric oxide Mice 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine Animals Swimming Biological Psychiatry biology Mood Disorders Antidepressive Agents Nitric oxide synthase Psychiatry and Mental health NG-Nitroarginine Methyl Ester 030104 developmental biology medicine.anatomical_structure chemistry Lithium Compounds biology.protein Drug Therapy Combination 030217 neurology & neurosurgery Signal Transduction Behavioural despair test medicine.drug |
| Zdroj: | Psychiatry Research. 266:262-268 |
| ISSN: | 0165-1781 |
| DOI: | 10.1016/j.psychres.2018.03.010 |
| Popis: | Lithium is still the main agent in the management of mood disorders such as depression. Likewise, agmatine protects the central nervous system (CNS) against depression. The aim of the present study was to examine the possible additive antidepressant-like effect of agmatine and lithium in mice forced swim test (FST) as well as exploration of the probable involvement of nitric oxide (NO) pathway in this response. Results showed that pretreatment with a subeffective dose of agmatine (0.01 mg/kg) augmented the antidepressant-like effect of lithium subeffective dose (3 mg/kg) (P 0.001). L-NG-nitroarginine methyl ester (L-NAME, nonspecific nitric oxide synthase [NOS] inhibitor) at doses of 10 and 30 mg/kg, and 7-nitroindazole (7-NI, neuronal NOS inhibitor) at doses of 15 and 30 mg/kg potentiated the antidepressant-like effect of the subeffective combination of lithium (3 mg/kg) and agmatine (0.001 mg/kg) (P 0.001, P 0.01, respectively). However, various doses of aminoguanidine (25 and 50 mg/kg, inducible NOS inhibitor) failed to alter the immobility time of the same combination (P 0.05). Moreover, pretreatment with subeffective doses of L-arginine (substrate for NOS, 300 and 750 mg/kg) reversed the augmenting antidepressant-like effect of agmatine (0.01 mg/kg) on lithium (3 mg/kg) (P 0.001). Our results revealed that agmatine enhances the antidepressant-like effects of lithium and the NO pathway might mediate this phenomenon. In addition, constitutive NOS plays a dramatic role in this response. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect